Atovaquone
- Product NDC
- 66689-062
- 11-digit product format
- 666890062
- Labeler code
- 66689
- Product ID
- 66689-062_49610dc8-3716-4f7c-a2db-5f7ec9d0838d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atovaquone
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- VistaPharm, Inc.
- Application
- ANDA202960
- Marketing category
- ANDA
- Marketing start
- 2018-09-14
- Marketing end
- 0000-00-00
- Substance
- ATOVAQUONE
- Active strength
- 750 mg/5mL
- Pharmacologic classes
- Antimalarial [EPC],Antiprotozoal [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66689-062-18 | 66689006218 | 18 POUCH in 1 CASE (66689-062-18) > 1 mL in 1 POUCH (66689-062-01) | 18 pouch | 2018-09-14 | 0000-00-00 | No | No | Current |
| 66689-062-42 | 66689006242 | 42 POUCH in 1 CASE (66689-062-42) > 1 mL in 1 POUCH (66689-062-01) | 42 pouch | 2018-09-14 | 0000-00-00 | No | No | Current |